ArticleProstate cancer and prostatic diseases2026
Feasibility and safety of single-port transvesical simple prostatectomy in patients with very large prostates: A volume-stratified analysis.
Article in Prostate cancer and prostatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSingle-port transvesical robot-assisted simple prostatectomy (SP-SP) is a minimally invasive treatment option for patients with large prostates. However, the impact of prostate volume on perioperative outcomes, particularly in patients with extremely large glands, has not been systematically evaluated. This study aimed to assess the safety and efficacy of SP-SP across different prostate volume strata. MATERIALS AND
methodsWe retrospectively reviewed 90 consecutive patients who underwent SP-SP between 2020 and 2025 by a single surgeon. Patients were stratified by preoperative total prostate volume (TPV) into Group A (80-120 mL, n = 43), Group B (120-160 mL, n = 22), and Group C (>160 mL, n = 25). Perioperative parameters were compared among the three groups. Multivariate logistic regression analysis was performed to identify risk factors for postoperative complications.
resultsBaseline characteristics were generally comparable among groups. Pairwise comparisons showed that patients in Group C had significantly higher preoperative PSA levels than those in Group A, as well as longer operative time and greater estimated blood loss (EBL) compared with both Groups A and B. Aside from postoperative hemoglobin levels, recovery and safety outcomes were largely similar across groups. Multivariate analysis identified EBL as the only independent risk factor for postoperative complications, while TPV was not independently associated with complications. Specimen weight increased with increasing prostate volume, while the resection ratio was similar across groups. At the last follow-up, significant improvements were observed in PSA, PVR, IPSS, and QoL scores, as well as in the urinary continence across the three groups, with no significant differences between groups.
conclusionsThese findings provide preliminary evidence supporting the feasibility of SP-SP in patients with very large prostates. Larger multicenter studies with adequate sample sizes and longer follow-up are warranted to further evaluate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.